Patidegib Gel 2%
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Patidegib Gel 2%, covering 2019-07-15 to 2026-08-11. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of Patidegib Gel 2% for Preventing Basal Cell Carcinomas on the Face of Adults With Gorlin Syndrome [Phase 3]